Click Here to return To Results

 

Intrathecal Administration of Autologous Mesenchymal Stem Cells in Multiple System Atrophy Neurol 93:e77-e87, Singer, W.,et al, 2019 See this aricle in Pubmed Article Abstract Intrathecal MSC administration in MSA is safe and well-tolerated but can be associated with a painful implantation response at high doses. Compelling dose-dependent efficacy signals are the basis for a planned placebo-controlled trial.

Related Tags

(click to filter results - removes previous filter) intrathecal medication multiple system atrophy stem cell transplantation treatment of neurologic disorder

Click Here to return To Results